Based on linkage analyses conducted in the 1990s, patients with mutations in the MAPT gene and tau deposits in neuronal and glial cells were classified as having FTD and parkinsonism linked to chromosome 17q21 (FTDP-17) [21]. The gene discussed is MAPT; the disease is Parkinsonism.